Both in Pharmaceuticals
TherapeuticsMD vs Atossa Therapeutics
Over the past year TXMD returned +54.8% and ATOS returned −82.0%; their daily moves had a correlation of 0.05.
TXMD +54.8% ATOS −82.0%Growth of $1, one year, split-adjusted
| Metric | TXMD | ATOS |
|---|---|---|
| Price | $1.78 | $2.33 |
| Market cap | $20.6M | $23.3M |
| Today | −1.66% | +1.30% |
| 1 month | −11.4% | −4.9% |
| 6 months | −14.0% | −58.2% |
| Year to date | +9.2% | −73.7% |
| 1 year | +49.6% | −82.5% |
| Revenue growth (YoY) | −8.7% | — |
| Gross margin | 100.0% | — |
| Net margin | 17.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.3× | — |
| Net cash | $9.2M | $26.1M |
| Dividend yield | — | — |
| Volatility (60d) | 33.8% | 76.6% |
| Short % of float | 0.2% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).